CHF applauds the PSA’s renewed commitment to quality, safety, and meeting evolving community needs. We support the PSA’s intention to expand pharmacist roles but feel that this discussion paper has focused too much on community pharmacists and has overlooked the possibilities for hospital and consultant pharmacists, particularly at the point of clinical handover when communication between GPs and community pharmacies is crucial. With the title ‘Pharmacists in 2023’, CHF does wonder where PSA sees hospital pharmacists and consultant pharmacists fitting in and whether organisations like the Society for Hospital Pharmacists of Australia (SHPA) have been consulted in this vision.